Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials

Julien Taı̈eb, Frank A. Sinicrope, Levi Pederson, Sara Lonardi, Steven R. Alberts, Thomas J. George, Greg Yothers, Eric Van Cutsem, Leonard B. Saltz, Shuji Ogino, Rachel Kerr, Takayuki Yoshino, Richard M. Goldberg, Thierry André, Pierre Laurent‐Puig, Q. Shi